Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial update for CKD-215 and D215 in BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancer; not yet r…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation [Phase 1]
NT-175 is being studied in a Phase 1 trial enrolling adults with unresectable, advanced, or metastatic solid tumors positive for HLA-A*02:01…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer [NA]
A clinical trial comparing PET/MR to contrast-enhanced CT for imaging ovarian cancer patients or those with highly suspected ovarian cancer;…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study [NA]
This US cohort study is evaluating the safety of performing a risk-reducing salpingectomy with delayed oophorectomy as an alternative to imm…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
Clinical trial update describing an infertility survey for reproductive-age women with breast cancer and gynecologic cancers; the study is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments [Phase 1, Phase 2]
The document reports a Phase 1/2 clinical trial of XNW28012 for advanced solid tumors, including pancreatic cancer, with recruiting ongoing.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
A bidirectional cohort study to evaluate prophylactic resection surgery in individuals at moderate-to-high risk for hereditary ovarian cance…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging [Phase 1]
Phase 1 clinical trial evaluating metabolic imaging to assess the aggressiveness of ovarian cancer. The study status is suspended.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Cost Utility of Radical Surgery in Ovarian Cancer [NA]
A completed clinical trial evaluating the cost effectiveness of radical surgery for ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression [Phase 2]
Phase 2 study of INCB123667 for platinum‑resistant ovarian cancer with Cyclin E1 overexpression is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of XMT-1660 in Participants With Solid Tumors [Phase 1]
Phase 1 study of XMT-1660 in participants with solid tumors is currently recruiting. The trial lists indications including triple-negative b…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
A National Cancer Institute trial is recruiting to collect blood from patients with various cancers for genetic analysis.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing [Phase 3]
This trial update describes a continued access study for participants who benefit from Pfizer-sponsored avelumab parent studies that are clo…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers [Phase 2]
Phase 2 trial update for relacorilant in combination with different regimens in gynecologic cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Trial of THEO-260 in Ovarian Cancer Patients [Phase 1, Phase 2]
Phase 1/2 trial update shows THEO-260 being studied for ovarian cancer and currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Elements of Adaptive Immunity in Epithelial Ovarian Cancer
A completed clinical trial update examining elements of adaptive immunity in epithelial ovarian cancer, specifically the high-grade serous s…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells [Phase 1]
Phase 1 clinical trial evaluating autologous CAR-T cells targeting B7-H3 (iC9-CAR.B7-H3 T Cells) for ovarian cancer, currently recruiting at…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies [Phase 1]
This is a Phase 1 clinical trial evaluating individual responses to hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcino…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer [Phase 2]
Phase 2 clinical trial evaluating niraparib in combination with bevacizumab for ovarian cancer after complete cytoreduction; recruitment is …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial [Phase 2]
A Phase 2 ComboMATCH trial evaluates the combination of palbociclib and binimetinib in RAS-mutant cancers, including pancreatic and ovarian …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PF-07104091 as a Single Agent and in Combination Therapy [Phase 2]
Pfizer's PF-07104091 is being studied as a single agent and in combination therapy in Phase 2 trials for small cell lung cancer, ovarian can…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: GEN1047 for Solid Tumors - First in Human (FIH) Trial [Phase 1, Phase 2]
Genmab's GEN1047 first-in-human Phase 1/2 trial in solid tumors has been terminated, with indications including breast cancer, endometrial c…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial update investigates pembrolizumab in combination with aflibercept in patients with advanced cancers, including melanoma, col…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…